Emerging approaches to induce immune tolerance to therapeutic proteins
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging approaches to induce immune tolerance to therapeutic proteins
Authors
Keywords
-
Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-29
DOI
10.1016/j.tips.2023.10.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant Factor VIII Fc Fusion Protein for First-time Immune Tolerance Induction: Final Results of the verITI-8 Study
- (2023) Lynn Daniel Malec et al. BLOOD
- Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
- (2023) Sangwook Oh et al. NATURE BIOTECHNOLOGY
- Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis
- (2023) Ilja Oomen et al. Research and Practice in Thrombosis and Haemostasis
- Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
- (2023) Priya Bahri et al. DRUG SAFETY
- PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens
- (2023) Martina Damo et al. NATURE
- Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
- (2023) Alan Kivitz et al. Rheumatology and Therapy
- Bortezomib in relapsed/refractory immune thrombotic thrombocytopenic purpura: A single‐centre retrospective cohort and systematic literature review
- (2023) Nicholas C. J. Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Role of inhibitory signaling in peripheral B cell tolerance*
- (2022) Andrew Getahun IMMUNOLOGICAL REVIEWS
- Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
- (2022) Earl Sands et al. Nature Communications
- Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
- (2022) Naomi Schlesinger et al. BIODRUGS
- Surface conjugation of antibodies improves nanoparticle uptake in bronchial epithelial cells
- (2022) Valerie L. Luks et al. PLoS One
- Nanoparticle dose and antigen loading attenuate antigen‐specific T‐cell responses
- (2022) Liam M. Casey et al. BIOTECHNOLOGY AND BIOENGINEERING
- I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
- (2022) Laurent Peyrin-Biroulet et al. Clinical Gastroenterology and Hepatology
- Comparative Safety and Effectiveness of Biologic Therapy for Crohn’s Disease: A CA-IBD Cohort Study
- (2022) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Regulatory Framework for Drug Development in Rare Diseases
- (2022) Joan M. Korth‐Bradley JOURNAL OF CLINICAL PHARMACOLOGY
- A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome
- (2022) Xavier Mariette et al. JCI Insight
- Induction of antigen-specific tolerance by hepatic AAV immunotherapy regardless of T cell epitope usage or mouse strain background
- (2022) Geoffrey D. Keeler et al. Molecular Therapy-Methods & Clinical Development
- Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles
- (2021) Petr O. Ilyinskii et al. Science Advances
- TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
- (2021) Ciarán P. Kelly et al. GASTROENTEROLOGY
- Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
- (2021) Jeremy P. Bost et al. ACS Nano
- Daratumumab in rituximab‐refractory autoimmune haemolytic anaemia
- (2021) Max J. Rieger et al. BRITISH JOURNAL OF HAEMATOLOGY
- The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B
- (2021) Jan Astermark et al. HAEMOPHILIA
- Secondary failure: immune responses to approved protein therapeutics
- (2021) H.A. Daniel Lagassé et al. TRENDS IN MOLECULAR MEDICINE
- Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16
- (2021) H.A. Daniel Lagassé et al. Frontiers in Immunology
- Effect of CpG Depletion of Vector Genome on CD8+ T Cell Responses in AAV Gene Therapy
- (2021) Thais B. Bertolini et al. Frontiers in Immunology
- Microfluidic-Generated Immunomodulatory Nanoparticles and Formulation-Dependent Effects on Lipopolysaccharide-Induced Macrophage Inflammation
- (2021) Nhu Truong et al. AAPS Journal
- Rational engineering of a functional CpG-free ITR for AAV gene therapy
- (2021) Xiufang Pan et al. GENE THERAPY
- Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells
- (2021) Motahareh Arjomandnejad et al. Molecular Therapy-Methods & Clinical Development
- Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells
- (2020) Manish Malviya et al. JOURNAL OF AUTOIMMUNITY
- Combined anti‐CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors
- (2020) Bhavya S. Doshi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
- (2020) Maria T. Georgescu et al. Frontiers in Immunology
- Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function
- (2020) Yuchi Honaker et al. Science Translational Medicine
- CALIBRATE: A Phase 2 Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
- (2020) Yemil Atisha‐Fregoso et al. Arthritis & Rheumatology
- Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort
- (2020) Ankit K. Desai et al. Frontiers in Immunology
- CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD
- (2020) Yuki Imura et al. JCI Insight
- An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance
- (2020) Ying-Li Luo et al. ACS Applied Materials & Interfaces
- Regulatory T cells: Master thieves of the immune system
- (2020) Billur Akkaya et al. CELLULAR IMMUNOLOGY
- Anti-CD20 treatment for B-cell malignancies: current status and future directions
- (2020) Christian Klein et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
- (2020) Jinmin Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblasts as a source of self-antigens for central immune tolerance
- (2020) Takeshi Nitta et al. NATURE IMMUNOLOGY
- Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
- (2020) Lennard Ostendorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- B cell depletion therapies in autoimmune disease: advances and mechanistic insights
- (2020) Dennis S. W. Lee et al. NATURE REVIEWS DRUG DISCOVERY
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Regulatory T cells mediate specific suppression by depleting peptide–MHC class II from dendritic cells
- (2019) Billur Akkaya et al. NATURE IMMUNOLOGY
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab
- (2019) Manuel Carcao et al. HAEMOPHILIA
- ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation
- (2019) Luis J. Cruz et al. MOLECULES
- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
- (2019) Shayesteh R. Ferdosi et al. Nature Communications
- Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes
- (2019) Michel Tenspolde et al. JOURNAL OF AUTOIMMUNITY
- Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review
- (2019) Ankit K. Desai et al. Annals of Translational Medicine
- Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
- (2019) Celine Kaegi et al. Frontiers in Immunology
- The Effect of CpG Sequences on Capsid-Specific CD8+ T Cell Responses to AAV Vector Gene Transfer
- (2019) ZhiQuan Xiang et al. MOLECULAR THERAPY
- 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)
- (2019) Steven Piccoli et al. Bioanalysis
- Immune tolerance induction: What have we learned over time?
- (2018) H.-H. Brackmann et al. HAEMOPHILIA
- Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis
- (2018) M. Carcao et al. HAEMOPHILIA
- Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells
- (2018) Yong Chan Kim et al. JOURNAL OF AUTOIMMUNITY
- Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells
- (2018) Ai-Hong Zhang et al. JOURNAL OF IMMUNOLOGY
- Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis
- (2018) Geoffrey D. Keeler et al. MOLECULAR THERAPY
- Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity
- (2018) Ronit Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluating and Mitigating the Immunogenicity of Therapeutic Proteins
- (2018) Zuben E. Sauna et al. TRENDS IN BIOTECHNOLOGY
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- Proteasome Inhibition with Bortezomib Induces Apoptosis of Long-Lived Plasma Cells in Steroid-Resistant or Relapsed Immune Thrombocytopaenia
- (2018) Guosheng Li et al. THROMBOSIS AND HAEMOSTASIS
- Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies
- (2018) Muhammad Sarfraz et al. Pharmaceutics
- Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy
- (2018) Zhicheng Le et al. ACS Applied Materials & Interfaces
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Rare Diseases: Drug Discovery and Informatics Resource
- (2017) Mingzhu Zhao et al. Interdisciplinary Sciences-Computational Life Sciences
- Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
- (2017) Sang-oh Han et al. Molecular Therapy-Methods & Clinical Development
- Regulatory T cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transfer
- (2017) Roland W. Herzog et al. CELLULAR IMMUNOLOGY
- A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins
- (2016) A.S. Rosenberg et al. CLINICAL IMMUNOLOGY
- Gene therapy for immune tolerance induction in hemophilia with inhibitors
- (2016) V. R. Arruda et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Reduction of Factor VIII Inhibitor Titers During Immune Tolerance Induction With Recombinant Factor VIII-Fc Fusion Protein
- (2016) Charles L. Groomes et al. PEDIATRIC BLOOD & CANCER
- Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments
- (2015) Robert P. Perrillo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancers Complicating Inflammatory Bowel Disease
- (2015) Laurent Beaugerie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses
- (2014) Y. C. Kim et al. BLOOD
- Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease
- (2014) Nynne Nyboe Andersen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?
- (2014) Pengmei Li et al. TRANSPLANT INTERNATIONAL
- Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
- (2013) J. Mahlangu et al. BLOOD
- Bacteremia in patients receiving TNF-alpha antagonists – A prospective multicenter study
- (2013) Pierre Loulergue et al. JOURNAL OF INFECTION
- The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver
- (2011) A. T. Martino et al. BLOOD
- Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy
- (2010) J. D. Finn et al. BLOOD
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
- (2008) Jinhai Wang et al. NATURE BIOTECHNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started